 Biological Products
"Biological Products" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Complex pharmaceutical substances, preparations, or matter derived from organisms usually obtained by biological methods or assay.
| Descriptor ID |
D001688
|
| MeSH Number(s) |
D20.215
|
| Concept/Terms |
Biological Products- Biological Products
- Biologic Products
- Products, Biologic
- Biologics
- Products, Biological
|
Below are MeSH descriptors whose meaning is more general than "Biological Products".
Below are MeSH descriptors whose meaning is more specific than "Biological Products".
This graph shows the total number of publications written about "Biological Products" by people in this website by year, and whether "Biological Products" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 | | 2000 | 1 | 0 | 1 | | 2003 | 2 | 0 | 2 | | 2004 | 1 | 0 | 1 | | 2007 | 2 | 0 | 2 | | 2008 | 2 | 2 | 4 | | 2009 | 1 | 0 | 1 | | 2010 | 2 | 0 | 2 | | 2011 | 3 | 2 | 5 | | 2012 | 3 | 2 | 5 | | 2013 | 2 | 1 | 3 | | 2014 | 2 | 1 | 3 | | 2015 | 3 | 0 | 3 | | 2016 | 6 | 3 | 9 | | 2017 | 6 | 3 | 9 | | 2018 | 6 | 1 | 7 | | 2019 | 14 | 7 | 21 | | 2020 | 12 | 5 | 17 | | 2021 | 18 | 5 | 23 | | 2022 | 22 | 2 | 24 | | 2023 | 21 | 2 | 23 | | 2024 | 13 | 5 | 18 | | 2025 | 8 | 2 | 10 | | 2026 | 5 | 2 | 7 |
To return to the timeline, click here.
Below are the most recent publications written about "Biological Products" by people in Profiles.
-
Sharp J, Strati P, Bhatta S, Huang JJ, Thomas C, Elghawy O, Reef D, Gorzewski A, Wang J, Shouse G, Reinert C, Teferra A, Velez ET, Pelcovits A, Ollila T, Clark W, Yazbeck V, Maakaron J, Kamdar M, Fitzgerald L, Danilov A, Karmali R, Grover NS, Barta SK, Voorhees TJ, Chen AI, Shadman M, Ahmed S, Epperla N. Real-world outcomes and toxicities of CAR-T in relapsed/refractory follicular lymphoma: a multicenter cohort study. Blood Adv. 2026 Jun 09; 10(11):3757-3768.
-
Pingeon O, Grellier N, Coulm B, Beghin D, Chambers C, Chasset F, Fautrel B, Julsgaard M, Restellini S, Dechartres A, Kirchgesner J, Marin B. Safety of advanced therapies during pregnancy in women with immune-mediated inflammatory diseases: a systematic review and meta-analysis. J Crohns Colitis. 2026 May 08; 20(5).
-
Anderson B, Pascal C, Butler MGK, Chin AR, Long AJ, Sindher SB, Anagnostou A, Arasi S, Bégin P, Ciaccio CE, Eiwegger T, Fiocchi A, Fleischer DM, Garcia-Llorett M, Kim EH, Leonard S, Maskatia ZR, Perrett KP, Shreffler W, Upton J, Chinthrajah RS. Biologics and Novel Therapeutics in Food Allergy. J Allergy Clin Immunol Pract. 2026 Apr; 14(4):762-770.
-
Gibbons JB, DiStefano M, Anderson GF, Kesselheim AS, Socal M. Brand Manufacturer Coupons and Pharmaceutical Product Hopping. JAMA Netw Open. 2026 Mar 02; 9(3):e262201.
-
Davis AE, Rhoads S, Wechsler ME. Emerging biologic targets in type 2 and non-type 2 asthma. Curr Opin Pulm Med. 2026 May 01; 32(3):210-219.
-
Meena S, Fatima F, Qais FA, Ramachandran S. Computational screening of natural plant and marine compounds as potential inhibitors of Mycobacterium tuberculosis dihydrodipicolinate synthase. Comput Biol Chem. 2026 Jun; 122:108936.
-
Haydek JP, Mohan R, Lew J, Oonk A, Cheng D, Ahmed W, Click B, Fennimore B, Gerich M, Patel SG, Wani S, Hou JK, Scott FI. Treat-to-Target Monitoring Adherence and Rates of Healthcare Utilization in Patients With Inflammatory Bowel Disease in a Regional Healthcare System. Clin Transl Gastroenterol. 2026 Jan 01; 17(1):e00942.
-
Oberle AJ, Abbas F, Adrish M, Agache I, Conroy M, Coz Yataco AO, Little FF, Mammen MJ, Anand MP, Reddy R, Solanki N, Holguin F. Biologic Management in Severe Asthma for Adults: An American College of Chest Physicians Clinical Practice Guideline. Chest. 2026 Feb; 169(2):336-348.
-
Wang E, Henley W, Larenas-Linnemann D, Bulathsinhala L, Tran TN, Wechsler ME, Aaron SD, Al-Ahmad M, Al-Lehebi R, Altraja A, Barker P, Beastall A, Belevskiy AS, Bergeron C, Bjermer L, Björnsdóttir US, Bosnic-Anticevich SZ, Bourdin A, Brusselle GG, Busby J, Canonica GW, Carter V, Chapman KR, Chapman N, Christoff GC, Cosio BG, Costello RW, Fingleton J, Fonseca JA, Gaga M, Gibson PG, Hansen S, Heaney LG, Heffler E, Hew M, Horiguchi T, Hoyte F, Hubbard RB, Iwanaga T, Jackson DJ, Katial R, Koh MS, Kostikas K, Kuna P, Lehmann S, Lehtimäki L, Louis R, Lúdvíksdóttir D, Lugogo N, Mahboub B, Martin N, Máspero J, Menzies-Gow AN, Mohan A, Murray RB, Nagano T, Papadopoulos NG, Papaioannou AI, Patel PH, Perez-de-Llano L, Perng DW, Peters MJ, Pfeffer PE, Pitrez PM, Pleasants RA, Popov TA, Porsbjerg CM, Puggioni F, Quinton A, Rhee CK, Sadatsafavi M, Salvi S, Scioscia G, Sheu CC, Sirena C, Taillé C, Taube C, Torres-Duque CA, Tsai MJ, Tunsäter A, Ulrik CS, Price DB. Response to Biologics Along a Gradient of T2 Involvement in Patients With Severe Asthma: A Data-Driven Biomarker Clustering Approach. J Allergy Clin Immunol Pract. 2025 Dec; 13(12):3296-3315.
-
Pavord I, Katial RK, Jackson DJ, Rogers L, Lega Hoyte FC, Smolen J, Wechsler ME, Akuthota P, Jackson DJ. Current data on biologics: Evaluating clinical remission in asthma. J Allergy Clin Immunol. 2025 Sep; 156(3S):S15-S19.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|